Related Experiment Videos
Progressive renal failure in patients with lupus nephritis
H Tanaka1, H Akama, N Tominaga
1Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
Journal of Internal Medicine
|September 1, 1993
Summary
Disease activity and corticosteroid response predict kidney failure progression in lupus nephritis patients. Higher activity and poor response indicate faster deterioration, highlighting the need for tailored treatment strategies.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Lupus nephritis is a severe complication of systemic lupus erythematosus.
- Understanding renal failure progression is crucial for patient management.
- Predictive factors for disease progression remain an area of active research.
Purpose of the Study:
- To examine how disease activity and corticosteroid treatment response influence the progression to renal failure in lupus nephritis.
- To identify key indicators of kidney function decline in these patients.
Main Methods:
- Retrospective clinical study involving 28 patients with progressive lupus nephritis.
- Quantified rapidity of progression using the slope of reciprocal serum creatinine values.
- Assessed lupus activity via the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI).
Main Results:
- The rate of kidney function decline correlated significantly with systemic and serological disease activity.
- Rapidity of progression was also closely linked to the patient's response to corticosteroid therapy.
- These findings suggest disease activity and treatment responsiveness are key determinants of renal outcomes.
Conclusions:
- Disease activity and response to corticosteroids are critical factors in predicting renal failure progression in lupus nephritis.
- Monitoring disease activity and treatment effectiveness is essential for managing lupus nephritis and preventing kidney failure.